Imagine Pharma Secures $32.5M Series A for Continued Development of Its Novel IMG-1 Polypeptide and Associated Programs
/PRNewswire/ -- Imagine Pharma, a biotech company focused on furthering the commercialization opportunities related to its novel IMG-1 polypeptide, today...
Source: prnewswire.com